Industrial Vacuum Blog

Resources to keep your plant and your people safe

INTERPHEX 2017: Get the First Look

March 20, 2017   5:41 pm
We’re excited to be back in New York City and showcase our newest products to the pharmaceutical industry at INTERPHEX 2017. Get the first look at booth #2537 and what you can expect to see this week: If you can’t make it to the show, get in touch with your local Nilfisk representative to learn more. Read More   >

Protecting Your Workers Against Exposure to Potent Compounds in Pharmaceutical Manufacturing

February 23, 2017   11:12 am
Over the past several years, the pharmaceutical industry has introduced a new range of highly potent active pharmaceutical ingredients, or HPAPIs. These HPAPIs allow drug manufacturers to create highly targeted drugs that work faster and at lower doses than traditional medicines. They are also extremely toxic. There are several types of drugs associated with HPAPI […] Read More   >

Top 10 Vacuum Solutions for the Pharmaceutical Industry

January 22, 2017   1:01 pm
All processes and equipment used in the pharmaceutical industry must meet stringent requirements. Above all, they must help drug manufacturers ensure their products are safe, pure, and effective. Here are our top 10 vacuum solutions for the pharmaceutical industry. GM80 CR The GM80 CR is our most popular cleanroom vacuum, in pharma and beyond. It’s […] Read More   >

5 Tools to Control Worker Exposure to Active Pharmaceutical Ingredients

November 16, 2016   1:07 pm
Pharmaceutical vacuum
Exposure to active pharmaceutical ingredients (APIs) presents health and safety risks for pharma company employees. Drugs are, after all, substances designed to have a specific effect on the human body. In recent years, as pharma companies tackle difficult diseases such as new cancers, we’ve seen drugs become more complex and their APIs more toxic. That […] Read More   >

Cross-Contamination: The Enemy of Safe, Pure, and Effective

October 31, 2016   9:00 am
Pharmaceutical Industry
As anyone in the pharma industry can attest, since about 2000, the number of FDA inspections has increased. The agency has more inspectors on the street and is issuing more warning letters. Between 2007 and 2013 alone, the number of FDA warning letters skyrocketed 78%, with biotech and pharma companies receiving a large portion of […] Read More   >
« Newer PostsOlder Posts »